12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers

• SINTX Techs (NASDAQ:SINT) stock moved upwards by 136.2% to $0.13 during Wednesday's regular session. The company's market cap stands at $15.9 million. The company's, Q1 earnings came out 2 days ago.
• T2 Biosystems (NASDAQ:TTOO) shares moved upwards by 45.55% to $6.06. The company's market cap stands at $81.9 million.
• Nutriband (NASDAQ:NTRB) shares rose 25.9% to $4.67. The company's market cap stands at $51.2 million.
• Bone Biologics (NASDAQ:BBLG) shares increased by 25.64% to $2.89. The company's market cap stands at $2.5 million. As per the news, the Q1 earnings report came out yesterday.
• OptimizeRx (NASDAQ:OPRX) shares moved upwards by 22.8% to $12.87. The market value of their outstanding shares is at $234.0 million. As per the press release, Q1 earnings came out yesterday.
• Eyenovia (NASDAQ:EYEN) stock increased by 20.57% to $1.0. The market value of their outstanding shares is at $50.7 million. As per the news, the Q1 earnings report came out today.

Losers

• Virpax Pharmaceuticals (NASDAQ:VRPX) stock decreased by 67.0% to $0.76 during Wednesday's regular session. As per the news, the Q1 earnings report came out 2 days ago.
• Aethlon Medical (NASDAQ:AEMD) stock fell 50.35% to $0.42. The company's market cap stands at $1.1 million.
• Yield10 Bioscience (NASDAQ:YTEN) stock decreased by 37.84% to $3.27. The company's market cap stands at $2.1 million.
• Bolt Biotherapeutics (NASDAQ:BOLT) shares declined by 33.12% to $0.88. The company's market cap stands at $33.6 million. The company's, Q1 earnings came out yesterday.
• Oncology Institute (NASDAQ:TOI) shares fell 18.91% to $0.73. The market value of their outstanding shares is at $54.2 million. As per the press release, Q1 earnings came out yesterday.
• TRACON Pharma (NASDAQ:TCON) shares declined by 18.27% to $1.61. The market value of their outstanding shares is at $3.6 million. The company's, Q1 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.